Suan, Rhex R.

HRN: 25-84-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/12/2024
11/18/2024
IV
50mg
Q24hours
Mastoid Abscess, Left
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: